Global Insulin Glargine Market Survey and Trend Research 2018
ReportPage
Report ID
2089
Published Date
10-Dec
No of Report Page
91
Report Category
Editor's Rating
US $5,200.00
US $5,200.00
US $2,600.00

  • Report Details 
    Summary
    
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).
    
This report describe
    More...
  • Table Of Content 
    Table of Content
    
Part 1 Industry Overview
    
    1.1 Insulin Glargine Industry
    
        1.1.1 Definition
    
        1.1.2 Industry Trend
    
    1.2 Industry Chain
    
        1.2.1 Upstream
    
        1.2.2 Technology
    
        1.2.3 Cost Structure
    
        1.2.4 Consumer Preference
    
        1.2.2 Downstream
    
Part 2 Industry Overall
    
    2.1 Industry History
    
    2.2 Development Prospect
    
    2.3 Competition Structure
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -